• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
  • ABOUT US
    • Presentation
    • People
    • Contact
  • Spanish
  • English

H2020. Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework

Inicio » EU Calls and Awards » Horizon Europe » Excellent Science » H2020. Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework

21 de August de 2020

A large amount of high-quality health data is collected during clinical studies, but these valuable data are not used to the extent they merit. Subject to appropriate legal grounds, these data could be used to enrich patients’ healthcare records to improve clinical decision-making and reduce duplication in procedures/investigations. In addition, returning clinical trial data to patients could allow them to contribute their data for additional scientific research, in particular for rare diseases where treatments and data are scarce or unavailable.

Objectives

This project has two main objectives, which are equally important:

  • The first one is to align local and pan-European implementations and best practice for handling personal data protection regulations in order to foster the harmonisation of the legal framework applicable to medical research in the Member States;
  • The second one is to deliver a pan-European prototype process to return clinical trial data to study participants, building on previous and ongoing EU-level activities on citizen-centric access to health records. This prototype process will be delivered as part of the project alongside a robust business plan to ensure its sustainability.

To support these objectives, the project will:

  • Define harmonised rules for complying simultaneously with data protection regulations, regulatory requirements and ethical standards in Europe. These rules are to be endorsed by appropriate regulatory bodies and patients;
  • Define which, when and how clinical trial data should be returned to study participants, including for integration in, or interconnection with, patients’ individual health records management files or applications and, where they exist, national and/or hospital EHR systems (for clarity, no ‘lay summaries’ or other expert analyses are within the scope of this project) and EHR standards such as EEHRxF;
  • Define data governance models for cases where individual clinical trial data is (or can be) utilised for both healthcare decision making and future research, taking into account previous and ongoing EU-level activities on data governance in these fields;
  • Ensure that the whole process, from collection of data to its destruction or anonymisation, including sharing of individual personal data, is aligned with the study participants’ expectations and the authorities and ethics committees’ standards and procedures, and documented in binding and/or approved standards or guidance documents.

Expected Impact

In their proposals, applicants should describe how the outputs of the project will contribute to the following impacts and include, wherever possible baseline, targets and metrics to measure impact:

  • For patients: the project results should empower patients by returning their clinical trial data to them and to their medical records. Data acquired during clinical trials will aid better shared medical decision-making and reduce duplication in procedures/investigations;
  • For healthcare professionals: enriched healthcare data obtained during clinical care should aid better clinical decision making and reduce duplication in patient procedures/investigations;
  • For EU research: giving patients control of their clinical trial data will open possibilities for ethical data re-use e.g. if the patients opt in to donate their data to a common data sharing platform;
  • For pharma: returning clinical trial data to study participants during study conduct has the potential to improve adherence to study procedures and improve overall patient retention. Facilitate conduct and setup of clinical studies as well as access to health data for research. Doing this in a meaningful way will further help to educate patients and in doing so empower them to be equal partners in the management of their disease;
  • For regulators: it is an opportunity to exchange opinions with counterparts from other countries and researchers to propose informed workable aligned positions;
  • From a societal perspective: the project will increase the transparency of clinical study and therefore increase the trust of patients in clinical research. At a time where clinical trials are increasingly complex, this may help with recruitment for studies and improve oversight by patients and regulators on clinical data re-use.

Deadline

29 September 2020 17:00:00 Brussels time

More information

Call

Publicaciones relacionadas:

H2020. EIC Horizon Prize for ‘Fuel from the Sun: Artificial Photosynthesis’ H2020. EIC Scalator Pilot H2020. International cooperation with Canada on advanced biofuels and bioenergy H2020. Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence medicinas y drogasH2020. Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas

H2020. EIC Horizon Prize for ‘Fuel from the Sun: Artificial Photosynthesis’ H2020. EIC Scalator Pilot H2020. International cooperation with Canada on advanced biofuels and bioenergy H2020. Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence medicinas y drogasH2020. Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. </p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información